Key facts
- It has raised $3.4M; the latest was Early Stage VC ($3.4M) in Oct 2025.
- Notable investors include Fulgur Ventures, Initial Capital.
- Status: Privately Held (backing).
Investors
2- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Antidote (UK)
- ·The full record, as it builds
Funding rounds
No funding rounds for Antidote (UK) are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Antidote (UK)
Operator of a Bitcoin-focused startup accelerator intended to catalyze innovation in fintech, AI and digital identity by supporting visionary founders with resources, mentorship and capital. The company offers a six-month accelerator program combining seed funding, office space, legal and development support and strategic mentorship, enabling customers to rapidly build, validate and scale their ventures in high-impact sectors while gaining access to investors, policymakers and a collaborative London-based ecosystem.
- Sector
- Financial Services
- HQ
- Leicester, United Kingdom
- Founded
- 2024
- Employees
- 4
- Website
- antidotebtc.com/
- Ownership
- Privately Held (backing)
Antidote (UK) doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Antidote (UK) shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Antidote (UK) in its N-PORT filings yet. We sweep new filings monthly.